Vimarsana
Biggest News Aggregation in the World

Ivantis Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ivantis Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ivantis Inc Today - Breaking & Trending Today

Sight Sciences Announces Successful $34 Million Patent Infringement Verdict Against Alcon and its Hydrus Microstent for Microinvasive Glaucoma Surgery - Vimarsana News

Sight Sciences Announces Successful $34 Million Patent Infringement Verdict Against Alcon and its Hydrus Microstent for Microinvasive Glaucoma Surgery

MENLO PARK, Calif., April 29, 2024 -- Sight Sciences, Inc. , an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the...

Minimally Invasive Glaucoma Surgery Devices Market - Vimarsana News

Minimally Invasive Glaucoma Surgery Devices Market

Dublin, Jan. 18, 2024 (GLOBE NEWSWIRE) -- The

Micro Invasive Glaucoma Surgery (MIGS) Devices Market is Likely to Upsurge CAGR of 33.3% by 2029 - Vimarsana News

Micro Invasive Glaucoma Surgery (MIGS) Devices Market is Likely to Upsurge CAGR of 33.3% by 2029

Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market business report introduces the basics of industry such as market definitions, classifications, applications and industry chain overview, after which it covers industry policies and plans, product specifications, manufacturing processes, cost structures and...

Micro Invasive Glaucoma Surgery (MIGS) Devices Market Size to Reach USD 5,995.46 Million Globally wi - Vimarsana News

Micro Invasive Glaucoma Surgery (MIGS) Devices Market Size to Reach USD 5,995.46 Million Globally wi

Micro invasive glaucoma surgery (MIGS) Market is used to treat open-angle glaucoma. Initially, to treat OAG, medication was given that reduced aqueous humor production or increased aqueous humor outflow. For mild to moderate OAG, traditionally, pharmacologic and laser treatment was performed. With the coming of micr...

Glaukos Announces First Quarter 2023 Financial Results - Vimarsana News

Glaukos Announces First Quarter 2023 Financial Results

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced financial results for the first quarter ended March 31, 2023. Key highl...